The variations in survival for blood patients across Europe are most likely caused by variations in quality of care between regions, according to a new study published in The Lancet Oncology. More than 560,400 participants aged 15 years and older who were diagnosed with lymphoid and myeloid cancers between 1997 and 2008 were compared and followed up to the end of 2008.

READ FULL ARTICLE Curated publisher From Medical News Today